
Netanyahu recovers from food poisoning, to rest for three days
The 75-year-old leader fell ill overnight and was diagnosed with intestinal inflammation and dehydration, requiring intravenous fluids.
Netanyahu will continue performing his duties remotely while following doctors' orders to recuperate.
'In accordance with his doctors' instructions, the prime minister will rest at home for the next three days and will manage state affairs from there,' his office stated.
The Israeli leader has faced previous health challenges, including a pacemaker implantation in 2023 and prostate removal last December following a urinary tract infection diagnosis.
His office assured the public that his current condition is being closely monitored. - Reuters

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Malaysia Sun
13 hours ago
- Malaysia Sun
$10mn of USAID contraceptives to be burned in France media
The shipment destined for poor nations ended up stuck in Europe due to the shutdown of the agency A $10 million shipment of US-funded contraceptives will be incinerated in France, after Washington rejected offers to send the supplies to poorer nations, Reuters reported on Wednesday. The stockpile - made up of birth control pills and implants - has been stuck in Belgium since early 2025, when President Donald Trump shut down USAID and froze foreign aid programs. The supplies were originally meant for distribution in developing countries. A State Department spokesperson confirmed the destruction plan, saying the disposal will cost around $167,000 and take place at a medical waste facility in France. The contraceptives are being stored in the city of Geel and will require dozens of truckloads and at least two weeks to move, sources told Reuters. Belgian authorities have attempted to prevent the destruction of the supplies yet ultimately failed to do so, having exhausted "all possible options to prevent the destruction, including temporary relocation." "Despite these efforts, and with full respect for our partners, no viable alternative could be secured. Nevertheless, Belgium continues to actively seek solutions to avoid this regrettable outcome," the country's Foreign Ministry said in a statement, adding that "sexual and reproductive health must not be subject to ideological constraints." Human rights groups that attempted to buy the supplies from Washington have also suggested the impending destruction is being driven by "ideological" motives rather than a desire to cut costs. Sarah Shaw, Associate Director of Advocacy at MSI Reproductive Choices, told Reuters the NGO approached Washington with an offer to pay for repackaging of the supplies without USAID branding and for shipment to their destinations, but the proposal was declined. "MSI offered to pay for repackaging, shipping, and import duties, but they were not open to that... We were told that the US government would only sell the supplies at the full market value," said Shaw. "This is clearly not about saving money. It feels more like an ideological assault on reproductive rights, and one that is already harming women," she added. The UN sexual and reproductive health agency, UNFPA, also reportedly offered to buy the shipment. The talks ultimately broke down, partially due to a lack of response from the US government, a source with direct knowledge told Reuters. (


The Star
17 hours ago
- The Star
China reports record wave of mosquito-borne chikungunya virus
Guangdong province has launched stricter anti-mosquito measures, including urging residents to clear stagnant water. -- PHOTO: UNSPLASH via The Straits Times/ANN BEIJING (Bloomberg): A city in China's southern industrial hub has recorded 3,195 chikungunya cases so far this month, the country's biggest outbreak of the mosquito-borne virus since it first emerged in the mainland nearly two decades ago. Foshan city - in Guangdong Province, just north of Hong Kong - first reported an imported chikungunya case earlier in July, China's national broadcaster CCTV said, citing briefings from local authorities. Infections have soared by more than 2,700 in the past week alone. While Chinese health officials have yet to explain what's behind the outbreak, Guangdong has launched stricter anti-mosquito measures, including urging residents to clear stagnant water and make sure drainage channels remain unobstructed. Chikungunya, first identified in 1952 in Tanzania, is transmitted to humans by infected mosquitoes, the World Health Organization says. The virus causes fever and severe joint pain, and other symptoms can include headaches, muscle pain, vomiting and fatigue. The outbreak in Guangdong, an often hot and humid area of southern China, is the latest sign that tropical diseases - from dengue to malaria and zika - are expanding their reach, as climate change lets mosquitoes live in new territories that have become warmer and wetter. Increased international travel and low population immunity are also helping the spread. An explosion in cases in the Indian Ocean since the start of 2025 has sparked concerns of a spread to other countries, leading the WHO to issue an urgent call to action this week, Reuters reported. France and Italy, thousands of miles from the region, have both found locally-acquired chikungunya cases this year. "The surge in chikungunya cases is likely due to favorable climatic conditions that allow blooms of the Aedes mosquito population,' said Robert Jones, Assistant Professor in the Department of Disease Control at the London School of Hygiene & Tropical Medicine. "These are aggressive, day-biting mosquitoes that thrive in warm, wet conditions.' More than five billion people live in areas across 119 countries at risk from chikungunya, the WHO told reporters in Geneva, Reuters said. Some 220,000 cases and 80 related deaths have been reported in 14 countries and territories globally so far this year, according to the European Centre for Disease Prevention and Control. China recorded its first chikungunya case in 2008, an imported infection detected at an airport in Guangdong. The first locally transmitted cases - infecting 253 people - were reported in the province two years later. Since then, only sporadic cases have been found, in Yunnan and Fujian provinces. Globally, population susceptibility is likely elevated in areas where chikungunya outbreaks haven't tended to occur, said Patricia Gallego Delgado, Associate Director at London-based disease forecasting firm Airfinity Ltd. The wave is "attributable to lower levels of population immunity as individuals in these regions may have had limited or no prior exposure to the virus,' she said. -- ©2025 Bloomberg L.P.


The Star
19 hours ago
- The Star
Novartis to pay Matchpoint up to $1 billion to develop anti-inflammatory therapies
FILE PHOTO: The company's logo is seen at the new cell and gene therapy factory of Swiss drugmaker Novartis in Stein, Switzerland, November 28, 2019. REUTERS/Arnd Wiegmann/File Photo (Reuters) -Swiss drugmaker Novartis will pay up to $1 billion to U.S. biotech Matchpoint Therapeutics to develop oral drugs for several inflammatory diseases. Matchpoint said on Thursday it will use its technology to develop drugs that block the activity of a specific protein, helping to lower the production of inflammation-causing signals. The company will lead the research and drug development process, using the funding from Novartis. If Novartis exercises its option to exclusively license the program, the drugmaker will have global rights to develop and commercialize all products resulting from the collaboration. Matchpoint said it will receive up to $60 million in upfront payment and research funding, with up to $1 billion in total potential payments, including option exercise fee, and development and commercial milestones. (Reporting by Christy Santhosh in Bengaluru; Editing by Sriraj Kalluvila and Shinjini Ganguli)